MedPath

A prospective, multicenter phamacoepidemiologic study for Korean rheumatoid arthritis patients who use biologic agents

Not Applicable
Recruiting
Conditions
Diseases of the musculo-skeletal system and connective tissue
Registration Number
KCT0000262
Lead Sponsor
Hanyang University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
1100
Inclusion Criteria

All rheumatoid arthritis patients who start biologic agents

Exclusion Criteria

Patients who do not give written informed consent to participate in the this registry

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of tuberculosis in RA patients
Secondary Outcome Measures
NameTimeMethod
incidence of malignancy in RA patients
© Copyright 2025. All Rights Reserved by MedPath